Palirodenum Uses, Dosage, Side Effects and more
Palirodenum is an orally active neurotrophic, non-peptidic compound that activates synthesis of endogenous neurotrophines. Studies show that use of paliroden increased the rate of formation of both neural progenitors and mature neurons. It is indicated for use in Alzheimer's Disease and Parkinson’s.
SR 57667 is an orally active neurotrophic, non-peptidic compound that activates synthesis of endogenous neurotrophines. Studies show that use of SR 57667 increased the rate of formation of both neural progenitors and mature neurons.
| Attribute | Details |
|---|---|
| Trade Name | Palirodenum |
| Generic | Paliroden |
| Paliroden Other Names | Paliroden, Palirodenum |
| Type | |
| Formula | C26H24F3N |
| Weight | Average: 407.48 Monoisotopic: 407.186084266 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in Alzheimer's disease and Parkinson's disease.
How Palirodenum works
SR 57667 may be an irreversible MAOB inhibitor.
